Cancer Immunology & Immunotherapy

The relation of the immune system with cancer is known for many decades. Harnessing the host immune response to specifically target tumor cells holds promise as a strategy to fight cancer. Although the potential of this strategy remains solid, the approach still requires optimization. Current approaches in cancer immunotherapy include the use of antibodies, cytokines, tumor antigen vaccines, dendritic cells, T cells and NK cells.

So far "passive" immunotherapy has experienced the greatest success, with antibody and cytokine therapies leading the way and being already established in the clinical setting.

Get in touch with the Institute of Molecular Medicine & Biomedical Research

Contact us


Subscribe to our Newsletter and stay up to date!
Terms and Conditions


Please feel free to contact us using the below contact details for further information.